Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

Rogier A. Oldenburg(Erasmus MC), Hanne Meijers‐Heijboer(Erasmus MC), Monique van Veghel‐Plandsoen(Erasmus MC), Anja de Snoo(Erasmus MC), Ans van den Ouweland(Erasmus MC), Ellen Crepin(Erasmus MC), Marijke Wasielewski(Erasmus MC), Hanne Meijers‐Heijboer(Erasmus MC), Fons Elstrodt(Erasmus MC), Jan G.M. Klijn(Erasmus MC), Antoinette Hollestelle(Erasmus MC), Mieke Schutte(Erasmus MC), M.P.W.A. Houben(Erasmus MC), Cornelia M. van Duijn(Erasmus MC), Carina C. M. Bartels(Erasmus MC), Carel Meijers(University of Cambridge), Deborah J. Thompson(University of Cambridge), Lesley McGuffog(University of Cambridge), Douglas F. Easton(University of Cambridge), Rita Barfoot(Institute of Cancer Research), Michael R. Stratton(Institute of Cancer Research), Rosalind A. Eeles(Institute of Cancer Research), Nazneen Rahman(Institute of Cancer Research), Sheila Seal(Institute of Cancer Research), Nayanta Sodha(Institute of Cancer Research), Jon Mangion(Institute of Cancer Research), Richard S. Houlston(Institute of Cancer Research), Jenny Chang‐Claude(St George's, University of London), Diana Eccles(University of Toronto), D. Gareth Evans(Hadassah Medical Center), Victoria Murday(St George's Hospital), Catherine Phelan(Women's College Hospital), Steven A. Narod(Women's College Hospital), T. Peretz(Centre international de recherche sur le cancer), Julian Peto(Leiden University), Julian Peto(Institute of Cancer Research), Barbara L. Weber(University of Pennsylvania), Hong Xiang Zhang(California University of Pennsylvania), Katherine L. Nathanson(California University of Pennsylvania), David E. Goldgar(Centre international de recherche sur le cancer), Csilla I. Szabo(Institute of Cancer Research), Peter Devilee(Leiden University), Michael R. Stratton(Institute of Cancer Research), P. Andrew Futreal(Wellcome Sanger Institute)
Nature Genetics
April 22, 2002
Cited by 1,108Open Access
Full Text

Abstract


Related Papers